Maggie Loughran
Associate Manager Regeneron Pharmaceuticals
Maggie Loughran has six years of experience at Regeneron, where she specializes in supporting Managed Access Programs across all therapeutic areas and driving Real-World Evidence (RWE) generation. She holds a Bachelor of Science in Biology and a Master of Public Health in Epidemiology, which fuel her passion for expanding patient access to innovative therapies and leveraging data for impactful decision-making. Maggie plays a pivotal role in bridging clinical research and patient care.
Seminars
Wednesday 25th March 2026
The Role of Compassionate Use & Expanded Access Programs in Epidemics & Pandemics: A Look at COVID-19 & Ebola
2:00 pm
- Examine how Compassionate Use and Expanded Access Programs operate in fast-moving outbreaks, using Ebola and COVID-19 to illustrate the clinical, regulatory, and ethical landscape
- Compare two approaches our team deployed in each outbreak, explaining when and why they were chosen, how they were implemented, and their impact on patient access
